Methodological insights from health valuation studies in low- and middle-income countries : a scoping review

dc.contributor.authorGadsden, Thomas
dc.contributor.authorVerstraete, Janine
dc.contributor.authorMoyo, Audrey
dc.contributor.authorCarries, Stanley
dc.contributor.authorSithole, Nokwanda
dc.contributor.authorDavids, Eugene Lee
dc.contributor.authorBesada, Donela
dc.contributor.authorAngell, Blake J.
dc.contributor.authorJan, Stephen
dc.contributor.authorGovindasamy, Darshini
dc.date.accessioned2025-11-06T06:52:55Z
dc.date.issued2025
dc.description.abstractOBJECTIVES : Valuation studies generate utility values for health states using stated preference methods. These studies are complex and resource-intensive, posing implementation challenges in low- and middle-income countries (LMICs). This review aimed to examine how valuation studies in LMICs have navigated these challenges. METHODS : A scoping review was conducted, with database (MEDLINE, EMBASE, and CINAHL) and gray literature searches performed between April and June 2024. Inclusion was limited to valuation studies in LMICs using generic or disease-specific instruments and stated preference techniques with adult respondents and published in English. Results were narratively synthesized. RESULTS : A total of 36 studies from 22 LMICs were included. Studies were conducted across low (n = 2), lower-middle (n = 11), and upper middle-income countries (n = 9). Half were published since 2020. There were 33 studies that developed nationally representative value sets, 2 of which were based on patient preferences. Two pilot studies and 1 cancer-specific value set were also included. The EQ-5D-5L was used most (n = 16), followed by the EQ-5D-3L (n = 14), Short Form-6 Dimension (n = 4), Chinese medicine Quality of life-11 Dimensions (n = 1), and European Organization for Research and Treatment of Cancer-8 dimension (n = 1). Methodological adaptations included “lite” protocols, portable tools, and crosswalk methodology. Comprehension aids were reported in 11 studies; 5 included illiterate participants, and 7 were conducted in multiple languages. CONCLUSIONS : Valuation studies are increasing rapidly in LMICs, and there is growing experimentation to reduce resource demands and enhance inclusivity. Although this is promising, the resource demands of valuation studies still limit their implementation in low-income settings. Therefore, these countries may still find it more cost-efficient to adapt value sets from neighboring countries rather than develop their own. HIGHLIGHTS • This review examines the use of strategies to reduce the resource demands and inclusivity of valuation studies in low- and middle-income countries. • Valuation studies have increased rapidly in low- and middle-income countries, and strategies are evolving to reduce resource burden (eg, “lite” protocols) and increase inclusivity. Nevertheless, the limited number of studies in low-income countries suggests that resource requirements remain a barrier. • Although further validation is needed, these emerging strategies have the potential to reduce entry costs for countries to conduct valuation studies and enable more inclusive, representative sampling.
dc.description.departmentPsychology
dc.description.embargo2026-09-02
dc.description.librarianhj2025
dc.description.sdgSDG-03: Good health and well-being
dc.description.sponsorshipThis work is supported by matched seed funding provided by The George Institute for Global Health and the South African Medical Research Council.
dc.description.urihttps://www.valueinhealthjournal.com/
dc.identifier.citationGadsden, T., Verstraete, J., Moyo, A. et al. 2025, 'Methodological insights from health valuation studies in low- and middle-income countries : a scoping review', Value in Health, pp. 1-11, doi : 10.1016/j.jval.2025.08.014.
dc.identifier.issn1098-3015 (print)
dc.identifier.issn1524-4733 (online)
dc.identifier.other10.1016/j.jval.2025.08.014
dc.identifier.urihttp://hdl.handle.net/2263/105134
dc.language.isoen
dc.publisherElsevier
dc.rights© 2025, International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. Notice : this is the author’s version of a work that was accepted for publication in Value in Health. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Value in Health, vol. , pp. , 2025. doi : 10.1016/j.jval.2025.08.014.
dc.subjectHealth-related quality of life
dc.subjectLow- and middle-income countries (LMICs)
dc.subjectHealth state valuation
dc.titleMethodological insights from health valuation studies in low- and middle-income countries : a scoping review
dc.typePostprint Article

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: